Company profile for ALMATICA PHARMA INC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Almatica Pharma, Inc. a subsidiary of Alvogen, is focused on the acquisition of brand Rx products. Established in 2008, Almatica Pharma has a current portfolio that includes Pain, Urology and nonsteroidal anti-inflammatory drugs (NSAIDs). Almatica is led by an experienced brand pharmaceutical management team and our current operations consist of established systems to support all aspects of brand product management including r...
Almatica Pharma, Inc. a subsidiary of Alvogen, is focused on the acquisition of brand Rx products. Established in 2008, Almatica Pharma has a current portfolio that includes Pain, Urology and nonsteroidal anti-inflammatory drugs (NSAIDs). Almatica is led by an experienced brand pharmaceutical management team and our current operations consist of established systems to support all aspects of brand product management including regulatory affairs, sales, marketing, customer service, and pharmacovigilance.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
10 Bloomfield Avenue Building B, Suite 2 Pinebrook, NJ 07058
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

MAGHREB Pharma Expo

MAGHREB Pharma Expo

Not Confirmed

envelop Contact Supplier

MAGHREB Pharma Expo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-12-2017-1491972590.pdf

FDA
12 Apr 2017

Drugs in Development

read-more
read-more

Details:

Through the acquisition, Bora will utilize Almatica's generic pharmaceutical products, including Zestril (lisinopril), an oral tablet used for treating hypertension, for commercialization purposes.


Lead Product(s): Lisinopril

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Zestril

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: TWi Pharmaceuticals

Deal Size: $38.5 million Upfront Cash: Undisclosed

Deal Type: Acquisition August 18, 2023

blank

01

MAGHREB Pharma Expo
Not Confirmed
MAGHREB Pharma Expo
Not Confirmed

Details : Through the acquisition, Bora will utilize Almatica's generic pharmaceutical products, including Zestril (lisinopril), an oral tablet used for treating hypertension, for commercialization purposes.

Product Name : Zestril

Product Type : Miscellaneous

Upfront Cash : Undisclosed

August 18, 2023

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact ALMATICA PHARMA INC and get a quotation

ALMATICA PHARMA INC is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Naproxen bulk with DMF offered by ALMATICA PHARMA INC

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN WALDRICK, NEW JERSEY. bulk offered by ALMATICA PHARMA INC

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN DEESIDE, UNITED KINGDOM. bulk offered by ALMATICA PHARMA INC

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty